ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Jian-Ti-Kang-Yi decoction alleviates poly(I:C)-induced pneumonia by inhibiting inflammatory response, reducing oxidative stress, and modulating host metabolism

Cui, Huantian; Wang, Yuming; Yu, Bolun; Wu, Yulin; Zhang, Gaijun; Guo, Junli; Luo, Junyu; Li, Qin; Li, Xiaojuan; He, Wenju; Wen, Weibo*; Liao, Jiabao*; Wang, Dongqiang*山东大学
Frontiers in Pharmacology2022-9-6DOI: 10.3389/fphar.2022.979400
1被引3阅读
引用收藏
分享

摘要

Jian-Ti-Kang-Yi decoction (JTKY) is widely used in the treatment of COVID-19. However, the protective mechanisms of JTKY against pneumonia remain unknown. In this study, polyinosinic-polycytidylic acid (poly(I:C)), a mimic of viral dsRNA, was used to induce pneumonia in mice; the therapeutic effects of JTKY on poly(I:C)-induced pneumonia model mice were evaluated. In addition, the anti-inflammatory and anti-oxidative potentials of JTKY were also investigated. Lastly, the metabolic regulatory effects of JTKY in poly(I:C)-induced pneumonia model mice were studied using untargeted metabolomics. Our results showed that JTKY treatment decreased the wet-to-dry ratio in the lung tissue, total protein concentration, and total cell count of the bronchoalveolar lavage fluid (BALF). Hematoxylin and Eosin (HE) and Masson staining indicated that the JTKY treatment alleviated the pathological changes and decreased the fibrotic contents in the lungs. JTKY treatment also decreased the expression of pro-inflammatory cytokines [interleukin (IL)-1 beta, IL-6, and tumor necrosis factor-alpha (TNF-alpha)] and increased the levels of immunomodulatory cytokines (IL-4 and IL-10) in the BALF and serum. Flow cytometry analysis showed that the JTKY treatment lowered the ratio of CD86(+)/CD206(+) macrophages in the BALF, decreased inducible nitric oxide synthase (iNOS) level, and increased arginase 1 (Arg-1) level in lung. JTKY also lowered CD11b(+)Ly6G(+) neutrophils in BALF and decreased myeloperoxidase (MPO) activity in lung. Moreover, it also elevated superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities and decreased methane dicarboxylic aldehyde (MDA) level in lung. Untargeted metabolomic analysis showed that the JTKY treatment could affect 19 metabolites in lung, such as L-adrenaline, L-asparagine, ornithine, and alpha-ketoglutaric acid. These metabolites are associated with the synthesis and degradation of ketone bodies, butanoate, alanine, aspartate, and glutamate metabolism, and tricarboxylic acid (TCA) cycle processes. In conclusion, our study demonstrated that treatment with JTKY ameliorated poly(I:C)-induced pneumonia. The mechanism of action of JTKY may be associated with the inhibition of the inflammatory response, the reduction of oxidative stress, and the regulation of the synthesis and degradation of ketone bodies, TCA cycle, and metabolism of alanine, aspartate, glutamate, and butanoate processes in lung.

学科与关键词

关键词
poly(I:C)-induced pneumoniaJian-Ti-Kang-Yi decoctionantiinflammatory effectanti-oxidative effectuntargeted metabolomics
相关
加载中…
  • Qing-Wen-Jie-Re Mixture Ameliorates Poly (I:C)-Induced Viral Pneumonia Through Regulating the Inflammatory Response and Serum Metabolism
    Li, Qin; Zhang, Tingrui; Wang, Yuming; Yang, Shangsong; Luo, Junyu; Fang, Fang; Liao, Jiabao; Wen, Weibo*; Cui, Huantian*; Shang, Hongcai*Frontiers in Pharmacology, 2022, 13: 891851.被引 7
  • Modified Jiu Wei Qiang Huo decoction improves dysfunctional metabolomics in influenza A pneumonia-infected mice
    Chen, Lijuan; Fan, Jiajun; Li, Yubin; Shi, Xunlong; Ju, Dianwen; Yan, Qianlin; Yan, Xin; Han, Lei; Zhu, Haiyan*Biomedical Chromatography, 2014, 28(4): 468-474.被引 28
  • Modified Xiaoqinglong decoction alleviates lipopolysaccharide-induced acute lung injury in mice by regulating arachidonic acid metabolism and exerting anti-apoptotic and anti-inflammatory effects
    Ruan, Yongdui*; Fan, Yaohua; Xie, Yanfeng; Ma, Chunling; Mo, Bingquan; Lai, Yanni; Li, Geng; Liu, Xiaohong*; Kuang, Weihong*Anatomical Record, 2022, 305(7): 1672-1681.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2022-09-06
卷期
第 13 卷
页码
979400
DOI
10.3389/fphar.2022.979400
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Science Foundation of China; Yunnan Province Major Science and Technology Special Project; Yunnan Provincial Science and Technology Department Science and Technology Program Key Research and Development Project; Research Projects in Key Areas of Traditional Chinese medicine in Tianjin; [81973800]; [82060864]; [2019ZF005]; [202103AC100005]; [2022007]

作者

  • C

    Cui, Huantian (第一作者)

    shandong univ

  • W

    Wang, Yuming

    tianjin univ tradit chinese med

查看全部 13 位作者收起作者
  • Y

    Yu, Bolun

    tianjin univ tradit chinese med

  • W

    Wu, Yulin

    tianjin med univ canc inst & hosp

  • Z

    Zhang, Gaijun

    tianjin univ tradit chinese med

  • G

    Guo, Junli

  • L

    Luo, Junyu

  • L

    Li, Qin

    yunnan univ tradit chinese med

  • L

    Li, Xiaojuan

  • H

    He, Wenju

    tianjin first cent hosp

  • W

    Wen, Weibo (通讯)

    yunnan univ tradit chinese med

  • L

    Liao, Jiabao (通讯)

  • W

    Wang, Dongqiang (通讯)

    tianjin first cent hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417